Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin Infusion for Ventricular Infarction Limitation
2012-002314-39Phase 3Completed
- Sponsor
- The Medicines Company
- Start
- Feb 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in myocardial infarction (MI) comparing Bivalirudin with Unfractionated heparin (2 arms). Primary endpoint: Infarct size by cardiac magnetic resonance imaging. Started Feb 2014; status: completed.
02
Drugs
bivalirudinheparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2012-002314-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002314-39.